6-bromoindirubin-3'-acetoxime,
BIO-acetoxime,
BIO-Acetoxime,
667463-85-6,
indirubin deriv. 8a,
GSK-3 Inhibitor X,
BIO-acetoxime (GSK-3 Inhibitor X),
740841-15-0,
AK198952,
AC1O6YPC,
6-bromoindirubin-3 -acetoxime,
BDBM7402,
CHEMBL430226,
[[(2Z)-2-(6-bromo-2-oxo-1H-indol-3-ylidene)indol-3-yl]amino] acetate,
DTXSID20648024,
EX-A2281,
BIO-Acetoxime, >=98% (HPLC),
IN1315,
MFCD09037533,
s7915,
6-BROMOINDIRUBIN-3'-ACETOXIME,
AKOS024457841,
AKOS025295610,
HY-15356,
RT-011514,
(2 Z,3 E)-6-Bromoindirubin-3 -acetoxime,
B5488,
CS-0005983,
(2Z,3E)-3-(acetoxyimino)-6'-bromo-[2,3'-biindolinylidene]-2'-one,
[(E)-[(2Z)-2-(6-bromo-2-oxo-indolin-3-ylidene)indolin-3-ylidene]amino] acetate,
3-{3-[(Acetyloxy)amino]-2H-indol-2-ylidene}-6-bromo-1,3-dihydro-2H-indol-2-one,
[(3E)-2-[(3Z)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-2,3-dihydro-1H-indol-3-ylidene]amino acetate,
3-{3-[(Acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene}-6-bromo-1,3-dihydro-2H-indol-2-one,
D0B3ZB,
CID6538818,
(2'Z,3'E)-6-Bromoindirubin-3'-acetoxime,